Benevir Biopharm

Benevir Biopharm

Benevir Biopharm

In the emerging field of oncolytic virotherapy, BeneVir is developing an improved therapeutic platform that can be adapted to target a wide variety of cancers.
Founded
2011
Raised
$5M
Follow us
Alexa global traffic share
Twitter followers
16 Feb 2016
$3,000,000
Venture capital

SEC FORM D

sec
26 Nov 2014
$2,000,000
Venture capital